Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression
- 1 March 2022
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (3) , 285-291
Abstract
Succinate is an important intermediate product of mitochondrial energy metabolism. Recent studies revealed that beyond its known traditional metabolic functions, succinate plays important roles in signal transduction, immunity, inflammation, and posttranslational modification. Recent studies showed that patients and mouse models with cardiovascular disease have high levels of serum succinate and succinate accumulation. Atherosclerosis (As) is the pathological basis of cardiovascular and peripheral vascular diseases, such as coronary heart disease, cerebral infarction, and peripheral vascular disease, and is a major factor affecting human health. This article reviews the progression of succinate in As diseases and its underlying mechanisms.Keywords
This publication has 64 references indexed in Scilit:
- Melatonin ameliorates Angiotensin II‐induced vascular endothelial damage via its antioxidative propertiesJournal of Pineal Research, 2013
- Renin inhibition in the treatment of diabetic kidney diseaseClinical Science, 2013
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary HypertensionCirculation Research, 2012
- Succinate reversesin-vitroplatelet inhibition by acetylsalicylic acid and P2Y receptor antagonistsPlatelets, 2011
- Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3‐kinase‐β signalingJournal of Thrombosis and Haemostasis, 2011
- High glucose and renin release: the role of succinate and GPR91Kidney International, 2010
- Triggering the succinate receptor GPR91 on dendritic cells enhances immunityNature Immunology, 2008
- Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotypeJournal of Applied Physiology, 2005
- Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent MechanismCirculation, 2005